Literature DB >> 28405733

Association of IL-1β, IL-1Ra and FABP1 gene polymorphisms with the metabolic features of polycystic ovary syndrome.

Nadia Rashid1, Aruna Nigam2, Pikee Saxena3, S K Jain4, Saima Wajid5.   

Abstract

BACKGROUND: Polycystic ovary syndrome (PCOS), a highly prevalent endocrinopathy is currently being designated as chronic low grade inflammatory state. IL-1β, IL-1Ra and FABP1 are critical mediators of inflammatory processes and are speculated to play a role in the pathogenesis of PCOS. The aim of this study was to study the association of IL-β, IL-1Ra and FABP1 gene polymorphisms with PCOS and related metabolic features.
SUBJECTS: 95 PCOS and 45 age matched healthy control subjects were enrolled in this study.
METHODS: Polymorphism in genes IL-1β, IL-1Ra and FABP1 was studied by PCR, PCR-RFLP and sequencing methods, respectively. Hormonal and lipid profiles were evaluated for all the subjects.
RESULTS: Hormonal and lipid profiles showed significant differences between PCOS and control subjects. Allele and genotype frequencies of IL-1β, IL-1Ra and FABP1 gene polymorphisms did not vary between the control and PCOS group. However, T allele of C[-511]T variant of IL-1β, allele II in intron 2 of IL-1Ra and A allele of A/G variant of FABP1 (rs2197076) showed significant association with many metabolic features associated with PCOS.
CONCLUSIONS: Polymorphism in genes encoding cytokines and proteins involved in lipid metabolism can provide insights into the genetics of the disease and may contribute to assess the associated risk of cardiovascular diseases (CVD), dyslipidemia and metabolic syndrome (MetS) associated with PCOS.

Entities:  

Keywords:  FABP1; IL-1Ra; IL-1β; Metabolic syndrome; PCOS

Mesh:

Substances:

Year:  2017        PMID: 28405733     DOI: 10.1007/s00011-017-1045-3

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  66 in total

1.  Ethnic-Specific Criteria for Classification of Body Mass Index: A Perspective for Asian Indians and American Diabetes Association Position Statement.

Authors:  Anoop Misra
Journal:  Diabetes Technol Ther       Date:  2015-04-22       Impact factor: 6.118

2.  Genetic polymorphisms of interleukin 1β gene and sporadic pancreatic neuroendocrine tumors susceptibility.

Authors:  Dimitrios Karakaxas; Anna Sioziou; Gerasimos Aravantinos; Ahmet Coker; Ioannis S Papanikolaou; Theodoros Liakakos; Christos Dervenis; Maria Gazouli
Journal:  World J Gastrointest Oncol       Date:  2016-06-15

3.  A better index of body adiposity.

Authors:  Richard N Bergman; Darko Stefanovski; Thomas A Buchanan; Anne E Sumner; James C Reynolds; Nancy G Sebring; Anny H Xiang; Richard M Watanabe
Journal:  Obesity (Silver Spring)       Date:  2011-03-03       Impact factor: 5.002

Review 4.  The Emerging Role of Chronic Low-Grade Inflammation in the Pathophysiology of Polycystic Ovary Syndrome.

Authors:  Soulmaz Shorakae; Helena Teede; Barbora de Courten; Gavin Lambert; Jacqueline Boyle; Lisa J Moran
Journal:  Semin Reprod Med       Date:  2015-07-01       Impact factor: 1.303

5.  [Correlation between interleukin-1 and the obesity of polycystic ovary syndrome].

Authors:  Yan Yang; Jie Qiao; Mei-zhi Li
Journal:  Zhonghua Fu Chan Ke Za Zhi       Date:  2012-01

6.  Lipid accumulation product is related to metabolic syndrome in women with polycystic ovary syndrome.

Authors:  S Xiang; F Hua; L Chen; Y Tang; X Jiang; Z Liu
Journal:  Exp Clin Endocrinol Diabetes       Date:  2013-02-20       Impact factor: 2.949

7.  Consensus on infertility treatment related to polycystic ovary syndrome.

Authors: 
Journal:  Hum Reprod       Date:  2008-03       Impact factor: 6.918

Review 8.  Fatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias.

Authors:  Friedhelm Schroeder; Avery L McIntosh; Gregory G Martin; Huan Huang; Danilo Landrock; Sarah Chung; Kerstin K Landrock; Lawrence J Dangott; Shengrong Li; Martin Kaczocha; Eric J Murphy; Barbara P Atshaves; Ann B Kier
Journal:  Lipids       Date:  2016-04-27       Impact factor: 1.880

9.  The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison.

Authors:  Henry S Kahn
Journal:  BMC Cardiovasc Disord       Date:  2005-09-08       Impact factor: 2.298

10.  A study of insulin resistance by HOMA-IR and its cut-off value to identify metabolic syndrome in urban Indian adolescents.

Authors:  Yashpal Singh; M K Garg; Nikhil Tandon; Raman Kumar Marwaha
Journal:  J Clin Res Pediatr Endocrinol       Date:  2013
View more
  5 in total

Review 1.  Potential genetic polymorphisms predicting polycystic ovary syndrome.

Authors:  Yao Chen; Shu-Ying Fang
Journal:  Endocr Connect       Date:  2018-04-05       Impact factor: 3.335

2.  FABP1 Polymorphisms Contribute to Hepatocellular Carcinoma Susceptibility in Chinese Population with Liver Cirrhosis: A Case-Control Study.

Authors:  Meng Wang; Xinghan Liu; Shuai Lin; Tian Tian; Feng Guan; Yan Guo; Xiao Li; Yujiao Deng; Yi Zheng; Peng Xu; Qian Hao; Zhen Zhai; Zhijun Dai
Journal:  J Cancer       Date:  2018-10-20       Impact factor: 4.207

3.  Association of IL-1β, IL-6, TNF-α, and TGFβ1 Gene Polymorphisms with Recurrent Spontaneous Abortion in Polycystic Ovary Syndrome.

Authors:  Afrah F Alkhuriji; Suliman Y Al Omar; Zainb A Babay; Manal F El-Khadragy; Lamjed A Mansour; Wazirah G Alharbi; Mahmoud I Khalil
Journal:  Dis Markers       Date:  2020-05-05       Impact factor: 3.434

4.  Effects of IL-18 on the proliferation and steroidogenesis of bovine theca cells: Possible roles in the pathogenesis of polycystic ovary syndrome.

Authors:  Hong Yuan Zhang; Fu Fan Zhu; Ying Jun Zhu; Yuan Jing Hu; Xu Chen
Journal:  J Cell Mol Med       Date:  2020-12-07       Impact factor: 5.295

Review 5.  Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India.

Authors:  Mohammad Ashraf Ganie; Vishnu Vasudevan; Imtiyaz Ahmad Wani; Mohammad Salem Baba; Tasleem Arif; Aafia Rashid
Journal:  Indian J Med Res       Date:  2019-10       Impact factor: 2.375

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.